These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8327994)

  • 1. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: influence of route of administration, sex and long-term ethanol treatment.
    van de Wiel JA; Fijneman PH; Duijf CM; Anzion RB; Theuws JL; Bos RP
    Toxicology; 1993 Jun; 80(2-3):103-15. PubMed ID: 8327994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration.
    Bouchard M; Viau C
    Can J Physiol Pharmacol; 1997 Mar; 75(3):185-92. PubMed ID: 9164700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of polycyclic aromatic hydrocarbons (PAH) and their metabolites in blood, feces, and urine of rats orally exposed to PAH contaminated soils.
    van Schooten FJ; Moonen EJ; van der Wal L; Levels P; Kleinjans JC
    Arch Environ Contam Toxicol; 1997 Oct; 33(3):317-22. PubMed ID: 9353210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the kinetics of various biomarkers of benzo[a]pyrene exposure following different routes of entry in rats.
    Moreau M; Bouchard M
    J Appl Toxicol; 2015 Jul; 35(7):781-90. PubMed ID: 25348660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of 3-hydroxy-benzo[a]pyrene after percutaneous penetration and oral absorption of benzo[a]pyrene in rats.
    Jongeneelen FJ; Leijdekkers CM; Henderson PT
    Cancer Lett; 1984 Dec; 25(2):195-201. PubMed ID: 6509438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
    Bouchard M; Viau C
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual values of excretion of benzo[a]pyrene metabolites and susceptibility to its carcinogenic effect in rats.
    Tyndyk ML; Zabezhinski MA; Bykov VJ; Dikun PP; Dymochka LA; Nepomnyaschaya OB; Yatsuk OS; Yermilov VB; Likhachev AJ
    Cancer Lett; 1994 Apr; 78(1-3):163-70. PubMed ID: 8180958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of long-term ethanol treatment on in vitro biotransformation of benzo(a)pyrene in microsomes of the liver, lung and small intestine from male and female rats.
    van de Wiel JA; Meuwissen M; Kooy H; Fijneman PH; Noordhoek J; Bos RP
    Biochem Pharmacol; 1992 Nov; 44(10):1977-84. PubMed ID: 1449516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of benzo[a]pyrene and 7,8-dihydro-7,8-dihydroxybenzo[a] pyrene in Fischer 344 rats: time distribution of total metabolites in blood, urine and feces.
    Uziel M; Haglund R
    Carcinogenesis; 1988 Feb; 9(2):233-8. PubMed ID: 3338106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for individual susceptibility to carcinogenic agents: excretion and carcinogenic risk of benzo[a]pyrene metabolites.
    Likhachev AJ; Beniashvili DSh; Bykov VJ; Dikun PP; Tyndyk ML; Savochkina IV; Yermilov VB; Zabezhinski MA
    Environ Health Perspect; 1992 Nov; 98():211-4. PubMed ID: 1336725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic modulation by human diet levels of dietary fibre and beef on metabolism and disposition of benzo[a]pyrene in the gastrointestinal tract of Fischer F344 rats.
    O'Neill IK; Povey AC; Bingham S; Cardis E
    Carcinogenesis; 1990 Apr; 11(4):609-16. PubMed ID: 2157557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo[a]pyrene and 3-OH-benzo[a]pyrene in rats.
    Cao D; Yoon CH; Shin BS; Kim CH; Park ES; Yoo SD
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2227-38. PubMed ID: 16326436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion and metabolism of 1-nitropyrene in rats after oral or intraperitoneal administration.
    Dutcher JS; Sun JD; Bechtold WE; Unkefer CJ
    Fundam Appl Toxicol; 1985 Apr; 5(2):287-96. PubMed ID: 3987999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism, bioavailability, and toxicokinetics of benzo(alpha)pyrene in F-344 rats following oral administration.
    Ramesh A; Inyang F; Hood DB; Archibong AE; Knuckles ME; Nyanda AM
    Exp Toxicol Pathol; 2001 Sep; 53(4):275-90. PubMed ID: 11665852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of compound M-11 and its metabolites with urine and feces in rats.
    Bastrygin DV; Viglinskaya AO; Kolyvanov GB; Litvin AA; Bochkov PO; Mozhaeva TY; Zherdev VP
    Bull Exp Biol Med; 2012 Sep; 153(5):707-9. PubMed ID: 23113264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The toxicokinetics of pyrene and its metabolites in rats.
    Viau C; Bouchard M; Carrier G; Brunet R; Krishnan K
    Toxicol Lett; 1999 Sep; 108(2-3):201-7. PubMed ID: 10511263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the chromatographic fractionation of metabolites of benzo[a]pyrene in faeces and urine from germfree and conventional rats.
    Egestad B; Pettersson P; Sjövall J; Rafter J; Hyvönen K; Gustafsson JA
    Biomed Chromatogr; 1987; 2(3):120-34. PubMed ID: 3507218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milk and urine excretion of polycyclic aromatic hydrocarbons and their hydroxylated metabolites after a single oral administration in ruminants.
    Lapole D; Rychen G; Grova N; Monteau F; Le Bizec B; Feidt C
    J Dairy Sci; 2007 Jun; 90(6):2624-9. PubMed ID: 17517702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
    Westerberg G; Wiklund L
    J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.